Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking

Archives of General Psychiatry

Volumn 55, Issue 8, 1998, Pages 683-690

  Hall, Sharon M ^a,b   Reus, Victor I ^a   Muñoz, Ricardo F ^a   Sees, Karen L ^a,b   Humfleet, Gary ^a   Hartz, Diane T ^a   Frederick, Sydney ^a   Triffleman, Elisa ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOXEPIN; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SMOKING CESSATION; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; PLACEBOS; SEX FACTORS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0031926898     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.8.683     Document Type: Article

References (33)

1. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA. 1990; 264:1541-1545.
2. Kandel D, Davies M. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry. 1986;43:255-262.
3. Covey LS, Tam D. Depressive mood, the single-parent home, and adolescent cigarette smoking. Am J Public Health. 1990;80:1330-1333.
4. Perez-Stable EJ, Marin G, Marin BV, Katz MH. Depressive symptoms and cigarette smoking among Latinos in San Francisco. Am J Public Health. 1990;80: 1500-1502.
5. Breslau N, Kilbey M, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry. 1991;48:1069-1074.
6. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA. 1988;259:2863-2866.
7. Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62: 141-146.
8. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry. 1990;31:350-354.
9. Ginsberg D, Hall SM, Reus VI, Muñoz RF. Mood and depression diagnosis in smoking cessation. Exp Clin Psychopharmacol. 1995;3:389-395.
10. Jacobs MA, Spilken AZ, Norman MM, Wohlberg GW, Knapp PH. Interaction of personality and treatment conditions associated with success in smoking control program. Psychosom Med. 1971;33:545-556.
11. Edwards NB, Murphy JK, Downs AD, Ackerman BJ, Rosenthal TL. Doxepin as an adjunct to smoking cessation: a double-blind pilot study. Am J Psychiatry. 1989;146:373-376.
12. Ferry LH, Robbins AS, Scariati PD, Masterson A, Abbey DE, Burchette RJ. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride [abstract]. Circulation. 1992;86(suppl):167.
13. Ferry LH, Burchette RJ. Evaluation of bupropion versus placebo for treatment of nicotine dependence. Paper presented at: American Psychiatric Association Scientific Session; May 26, 1994; Philadelphia, Pa. Presentation NR 554.
14. Niaura R, Goldstein MG, Depue J, Keuthen N, Kristeller J, Abrams D. Fluoxetine, symptoms of depression, and smoking cessation. Ann Behav Med. 1995;(suppl):S061.
15. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CK, Croghan IT, Sullivan PMI. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195-1202.
16. Schatzberg AF, Nemeroff CB, eds. American Psychiatric Press Textbook of Pharmacology. Washington, DC: American Psychiatric Press; 1995:147.
17. Zelman DC, Brandon TH, Jorenby DE, Baker TB. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol. 1992;60:943-952.
18. Hall SM, Muñoz R, Reus VI, Sees K, Duncan CD, Humfleet G, Hartz DT. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996;64:1003-1009.
19. Robins L, Helzer J, Croughan J, Ratcliff K. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
20. Mcnair D, Lorr M, Droppleman L. Manual for the Profile of Mood States. San Diego, Calif: Edits; 1971.
21. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology. 1976;50:35-39.
22. Beck AT, Ward CH, Mendelsohn M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
23. Blouin AG, Perez EL, Blouin JH. Computerized administration of the Diagnostic Interview Schedule. Psychiatry Res. 1988;23:335-344.
24. Speilberger DC, Gorsuch RL, Lustene RE. State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970.
25. Fagerstrom K. Measuring degree of physical dependence to tobacco smoking in reference to individualization of treatment. Addict Behav. 1978;3:235-241.
26. Fagerstrom KO. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159-182.
27. McCullagh P, Neider JA. Generalized Linear Models. 2nd ed. New York, NY: Whapman & Hall; 1989.
28. Gibbons R, Hedeker D, Waternaux C. Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. Psychopharmacology. 1988;24:438-443.
29. Gibbons R, Hedeker D, Elkin I, Waternaux C, Kraemer KH, Greehouse J, Shea T, Imber S, Sotsky S, Watkins J. Some conceptual and statistical issues in the analysis of longitudinal psychiatric data. Arch Gen Psychiatry. 1993;50:739-750.
30. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
31. Linnoila M, George L, Guthrie S, Leventhal B. Effects of alcohol consumption and cigarette smoking in antidepressant levels of depressed patients. Am J Psychiatry. 1981;138:841-842.
32. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli S, Fleiss J, Cooper TB. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther. 1993;54:670-679.
33. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry. 1992;149:464-469.